Alnylam Pharmaceuticals Aktie
231,10
EUR
-4,50
EUR
-1,91
%
237,97
USD
-4,57
USD
-1,88
%
Alnylam Pharmaceuticals Aktie Analyse
20.08.08 | Alnylam Pharmaceuticals underperform | Leerink Swann LLC | |
03.03.08 | Alnylam Pharmaceuticals underperform | Needham & Company, LLC |